JP Morgan Chase’s CM Life Sciences III Inc. Unit CMLTU Stock Holding History

JP Morgan Chase’s Portfolio CMLTU Stock Details CMLTU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-37,408	Closed	-$390K	–	7231
2021 Q3	$390K	Buy	+37,408	New	+$390K	﹤0.01%	4869

JP Morgan Chase's CMLTU Position: Q4 2021 in Review

JP Morgan Chase sold out of CM Life Sciences III Inc. Unit (CMLTU) in Q4 2021, closing a stake of 37,408 shares — an estimated $390K sold.

JP Morgan Chase first reported a position in CMLTU in Q3 2021 and held it in 1 quarter. The position peaked at $390K in Q3 2021. 0 funds tracked by Wall St. Rank hold CMLTU as of Q4 2021.

JP Morgan Chase reported no remaining CM Life Sciences III Inc. Unit position as of Q4 2021 after selling out during the quarter.
JP Morgan Chase sold 37,408 CM Life Sciences III Inc. Unit shares in Q4 2021, an estimated $390K.
JP Morgan Chase first reported a position in CM Life Sciences III Inc. Unit in Q3 2021 and held it in 1 quarter.
JP Morgan Chase's CM Life Sciences III Inc. Unit position peaked at $390K in Q3 2021.
0 funds tracked by Wall St. Rank held CM Life Sciences III Inc. Unit as of Q4 2021.

Based on JP Morgan Chase's 13F filing for Q4 2021, filed 10 Feb 2022.